Global Lung Cancer Genomic Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Lung Cancer Genomic Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Lung Cancer Genomic Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Lung Cancer Genomic Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Lung Cancer Genomic Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Lung Cancer Genomic Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Lung Cancer Genomic Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lung Cancer Genomic Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lung Cancer Genomic Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CD Genomics, Qiagen NV, Laboratory Corporation of America Holdings, NeoGenomics Laboratories and Agilent Technologies Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Lung Cancer Genomic Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Lung Cancer Genomic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lung Cancer Genomic Testing, with revenue, gross margin and global market share of Lung Cancer Genomic Testing from 2018 to 2023.
Chapter 3, the Lung Cancer Genomic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Lung Cancer Genomic Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Lung Cancer Genomic Testing.
Chapter 13, to describe Lung Cancer Genomic Testing research findings and conclusion.
This report is a detailed and comprehensive analysis for global Lung Cancer Genomic Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Lung Cancer Genomic Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Lung Cancer Genomic Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Lung Cancer Genomic Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Lung Cancer Genomic Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lung Cancer Genomic Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lung Cancer Genomic Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CD Genomics, Qiagen NV, Laboratory Corporation of America Holdings, NeoGenomics Laboratories and Agilent Technologies Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Lung Cancer Genomic Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Liquid Biopsy
- Tissue Biopsy
- Hospitals/Clinics
- Research Organization
- Diagnostic Laboratories
- CD Genomics
- Qiagen NV
- Laboratory Corporation of America Holdings
- NeoGenomics Laboratories
- Agilent Technologies Inc.
- Illumina Inc.
- Thermo Fischer Scientific Inc.
- Abbott Laboratories Inc.
- Quest Diagnostics Inc.
- OncoDNA
- Centogene N.V.
- Admera Health
- CeGaT GmbH
- OPKO Health Inc.
- F. Hoffmann-La Roche AG.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Lung Cancer Genomic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lung Cancer Genomic Testing, with revenue, gross margin and global market share of Lung Cancer Genomic Testing from 2018 to 2023.
Chapter 3, the Lung Cancer Genomic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Lung Cancer Genomic Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Lung Cancer Genomic Testing.
Chapter 13, to describe Lung Cancer Genomic Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Lung Cancer Genomic Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Lung Cancer Genomic Testing by Type
1.3.1 Overview: Global Lung Cancer Genomic Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Lung Cancer Genomic Testing Consumption Value Market Share by Type in 2022
1.3.3 Liquid Biopsy
1.3.4 Tissue Biopsy
1.4 Global Lung Cancer Genomic Testing Market by Application
1.4.1 Overview: Global Lung Cancer Genomic Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals/Clinics
1.4.3 Research Organization
1.4.4 Diagnostic Laboratories
1.5 Global Lung Cancer Genomic Testing Market Size & Forecast
1.6 Global Lung Cancer Genomic Testing Market Size and Forecast by Region
1.6.1 Global Lung Cancer Genomic Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Lung Cancer Genomic Testing Market Size by Region, (2018-2029)
1.6.3 North America Lung Cancer Genomic Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Lung Cancer Genomic Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Lung Cancer Genomic Testing Market Size and Prospect (2018-2029)
1.6.6 South America Lung Cancer Genomic Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Lung Cancer Genomic Testing Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 CD Genomics
2.1.1 CD Genomics Details
2.1.2 CD Genomics Major Business
2.1.3 CD Genomics Lung Cancer Genomic Testing Product and Solutions
2.1.4 CD Genomics Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CD Genomics Recent Developments and Future Plans
2.2 Qiagen NV
2.2.1 Qiagen NV Details
2.2.2 Qiagen NV Major Business
2.2.3 Qiagen NV Lung Cancer Genomic Testing Product and Solutions
2.2.4 Qiagen NV Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Qiagen NV Recent Developments and Future Plans
2.3 Laboratory Corporation of America Holdings
2.3.1 Laboratory Corporation of America Holdings Details
2.3.2 Laboratory Corporation of America Holdings Major Business
2.3.3 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product and Solutions
2.3.4 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.4 NeoGenomics Laboratories
2.4.1 NeoGenomics Laboratories Details
2.4.2 NeoGenomics Laboratories Major Business
2.4.3 NeoGenomics Laboratories Lung Cancer Genomic Testing Product and Solutions
2.4.4 NeoGenomics Laboratories Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 NeoGenomics Laboratories Recent Developments and Future Plans
2.5 Agilent Technologies Inc.
2.5.1 Agilent Technologies Inc. Details
2.5.2 Agilent Technologies Inc. Major Business
2.5.3 Agilent Technologies Inc. Lung Cancer Genomic Testing Product and Solutions
2.5.4 Agilent Technologies Inc. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Agilent Technologies Inc. Recent Developments and Future Plans
2.6 Illumina Inc.
2.6.1 Illumina Inc. Details
2.6.2 Illumina Inc. Major Business
2.6.3 Illumina Inc. Lung Cancer Genomic Testing Product and Solutions
2.6.4 Illumina Inc. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Illumina Inc. Recent Developments and Future Plans
2.7 Thermo Fischer Scientific Inc.
2.7.1 Thermo Fischer Scientific Inc. Details
2.7.2 Thermo Fischer Scientific Inc. Major Business
2.7.3 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product and Solutions
2.7.4 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Thermo Fischer Scientific Inc. Recent Developments and Future Plans
2.8 Abbott Laboratories Inc.
2.8.1 Abbott Laboratories Inc. Details
2.8.2 Abbott Laboratories Inc. Major Business
2.8.3 Abbott Laboratories Inc. Lung Cancer Genomic Testing Product and Solutions
2.8.4 Abbott Laboratories Inc. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Abbott Laboratories Inc. Recent Developments and Future Plans
2.9 Quest Diagnostics Inc.
2.9.1 Quest Diagnostics Inc. Details
2.9.2 Quest Diagnostics Inc. Major Business
2.9.3 Quest Diagnostics Inc. Lung Cancer Genomic Testing Product and Solutions
2.9.4 Quest Diagnostics Inc. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Quest Diagnostics Inc. Recent Developments and Future Plans
2.10 OncoDNA
2.10.1 OncoDNA Details
2.10.2 OncoDNA Major Business
2.10.3 OncoDNA Lung Cancer Genomic Testing Product and Solutions
2.10.4 OncoDNA Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 OncoDNA Recent Developments and Future Plans
2.11 Centogene N.V.
2.11.1 Centogene N.V. Details
2.11.2 Centogene N.V. Major Business
2.11.3 Centogene N.V. Lung Cancer Genomic Testing Product and Solutions
2.11.4 Centogene N.V. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Centogene N.V. Recent Developments and Future Plans
2.12 Admera Health
2.12.1 Admera Health Details
2.12.2 Admera Health Major Business
2.12.3 Admera Health Lung Cancer Genomic Testing Product and Solutions
2.12.4 Admera Health Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Admera Health Recent Developments and Future Plans
2.13 CeGaT GmbH
2.13.1 CeGaT GmbH Details
2.13.2 CeGaT GmbH Major Business
2.13.3 CeGaT GmbH Lung Cancer Genomic Testing Product and Solutions
2.13.4 CeGaT GmbH Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 CeGaT GmbH Recent Developments and Future Plans
2.14 OPKO Health Inc.
2.14.1 OPKO Health Inc. Details
2.14.2 OPKO Health Inc. Major Business
2.14.3 OPKO Health Inc. Lung Cancer Genomic Testing Product and Solutions
2.14.4 OPKO Health Inc. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 OPKO Health Inc. Recent Developments and Future Plans
2.15 F. Hoffmann-La Roche AG.
2.15.1 F. Hoffmann-La Roche AG. Details
2.15.2 F. Hoffmann-La Roche AG. Major Business
2.15.3 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product and Solutions
2.15.4 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 F. Hoffmann-La Roche AG. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Lung Cancer Genomic Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Lung Cancer Genomic Testing by Company Revenue
3.2.2 Top 3 Lung Cancer Genomic Testing Players Market Share in 2022
3.2.3 Top 6 Lung Cancer Genomic Testing Players Market Share in 2022
3.3 Lung Cancer Genomic Testing Market: Overall Company Footprint Analysis
3.3.1 Lung Cancer Genomic Testing Market: Region Footprint
3.3.2 Lung Cancer Genomic Testing Market: Company Product Type Footprint
3.3.3 Lung Cancer Genomic Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Lung Cancer Genomic Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Lung Cancer Genomic Testing Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Lung Cancer Genomic Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Lung Cancer Genomic Testing Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Lung Cancer Genomic Testing Consumption Value by Type (2018-2029)
6.2 North America Lung Cancer Genomic Testing Consumption Value by Application (2018-2029)
6.3 North America Lung Cancer Genomic Testing Market Size by Country
6.3.1 North America Lung Cancer Genomic Testing Consumption Value by Country (2018-2029)
6.3.2 United States Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Lung Cancer Genomic Testing Consumption Value by Type (2018-2029)
7.2 Europe Lung Cancer Genomic Testing Consumption Value by Application (2018-2029)
7.3 Europe Lung Cancer Genomic Testing Market Size by Country
7.3.1 Europe Lung Cancer Genomic Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
7.3.3 France Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Lung Cancer Genomic Testing Market Size by Region
8.3.1 Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Region (2018-2029)
8.3.2 China Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
8.3.5 India Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Lung Cancer Genomic Testing Consumption Value by Type (2018-2029)
9.2 South America Lung Cancer Genomic Testing Consumption Value by Application (2018-2029)
9.3 South America Lung Cancer Genomic Testing Market Size by Country
9.3.1 South America Lung Cancer Genomic Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Lung Cancer Genomic Testing Market Size by Country
10.3.1 Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Lung Cancer Genomic Testing Market Drivers
11.2 Lung Cancer Genomic Testing Market Restraints
11.3 Lung Cancer Genomic Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Lung Cancer Genomic Testing Industry Chain
12.2 Lung Cancer Genomic Testing Upstream Analysis
12.3 Lung Cancer Genomic Testing Midstream Analysis
12.4 Lung Cancer Genomic Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Lung Cancer Genomic Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Lung Cancer Genomic Testing by Type
1.3.1 Overview: Global Lung Cancer Genomic Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Lung Cancer Genomic Testing Consumption Value Market Share by Type in 2022
1.3.3 Liquid Biopsy
1.3.4 Tissue Biopsy
1.4 Global Lung Cancer Genomic Testing Market by Application
1.4.1 Overview: Global Lung Cancer Genomic Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals/Clinics
1.4.3 Research Organization
1.4.4 Diagnostic Laboratories
1.5 Global Lung Cancer Genomic Testing Market Size & Forecast
1.6 Global Lung Cancer Genomic Testing Market Size and Forecast by Region
1.6.1 Global Lung Cancer Genomic Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Lung Cancer Genomic Testing Market Size by Region, (2018-2029)
1.6.3 North America Lung Cancer Genomic Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Lung Cancer Genomic Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Lung Cancer Genomic Testing Market Size and Prospect (2018-2029)
1.6.6 South America Lung Cancer Genomic Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Lung Cancer Genomic Testing Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 CD Genomics
2.1.1 CD Genomics Details
2.1.2 CD Genomics Major Business
2.1.3 CD Genomics Lung Cancer Genomic Testing Product and Solutions
2.1.4 CD Genomics Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CD Genomics Recent Developments and Future Plans
2.2 Qiagen NV
2.2.1 Qiagen NV Details
2.2.2 Qiagen NV Major Business
2.2.3 Qiagen NV Lung Cancer Genomic Testing Product and Solutions
2.2.4 Qiagen NV Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Qiagen NV Recent Developments and Future Plans
2.3 Laboratory Corporation of America Holdings
2.3.1 Laboratory Corporation of America Holdings Details
2.3.2 Laboratory Corporation of America Holdings Major Business
2.3.3 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product and Solutions
2.3.4 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.4 NeoGenomics Laboratories
2.4.1 NeoGenomics Laboratories Details
2.4.2 NeoGenomics Laboratories Major Business
2.4.3 NeoGenomics Laboratories Lung Cancer Genomic Testing Product and Solutions
2.4.4 NeoGenomics Laboratories Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 NeoGenomics Laboratories Recent Developments and Future Plans
2.5 Agilent Technologies Inc.
2.5.1 Agilent Technologies Inc. Details
2.5.2 Agilent Technologies Inc. Major Business
2.5.3 Agilent Technologies Inc. Lung Cancer Genomic Testing Product and Solutions
2.5.4 Agilent Technologies Inc. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Agilent Technologies Inc. Recent Developments and Future Plans
2.6 Illumina Inc.
2.6.1 Illumina Inc. Details
2.6.2 Illumina Inc. Major Business
2.6.3 Illumina Inc. Lung Cancer Genomic Testing Product and Solutions
2.6.4 Illumina Inc. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Illumina Inc. Recent Developments and Future Plans
2.7 Thermo Fischer Scientific Inc.
2.7.1 Thermo Fischer Scientific Inc. Details
2.7.2 Thermo Fischer Scientific Inc. Major Business
2.7.3 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product and Solutions
2.7.4 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Thermo Fischer Scientific Inc. Recent Developments and Future Plans
2.8 Abbott Laboratories Inc.
2.8.1 Abbott Laboratories Inc. Details
2.8.2 Abbott Laboratories Inc. Major Business
2.8.3 Abbott Laboratories Inc. Lung Cancer Genomic Testing Product and Solutions
2.8.4 Abbott Laboratories Inc. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Abbott Laboratories Inc. Recent Developments and Future Plans
2.9 Quest Diagnostics Inc.
2.9.1 Quest Diagnostics Inc. Details
2.9.2 Quest Diagnostics Inc. Major Business
2.9.3 Quest Diagnostics Inc. Lung Cancer Genomic Testing Product and Solutions
2.9.4 Quest Diagnostics Inc. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Quest Diagnostics Inc. Recent Developments and Future Plans
2.10 OncoDNA
2.10.1 OncoDNA Details
2.10.2 OncoDNA Major Business
2.10.3 OncoDNA Lung Cancer Genomic Testing Product and Solutions
2.10.4 OncoDNA Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 OncoDNA Recent Developments and Future Plans
2.11 Centogene N.V.
2.11.1 Centogene N.V. Details
2.11.2 Centogene N.V. Major Business
2.11.3 Centogene N.V. Lung Cancer Genomic Testing Product and Solutions
2.11.4 Centogene N.V. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Centogene N.V. Recent Developments and Future Plans
2.12 Admera Health
2.12.1 Admera Health Details
2.12.2 Admera Health Major Business
2.12.3 Admera Health Lung Cancer Genomic Testing Product and Solutions
2.12.4 Admera Health Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Admera Health Recent Developments and Future Plans
2.13 CeGaT GmbH
2.13.1 CeGaT GmbH Details
2.13.2 CeGaT GmbH Major Business
2.13.3 CeGaT GmbH Lung Cancer Genomic Testing Product and Solutions
2.13.4 CeGaT GmbH Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 CeGaT GmbH Recent Developments and Future Plans
2.14 OPKO Health Inc.
2.14.1 OPKO Health Inc. Details
2.14.2 OPKO Health Inc. Major Business
2.14.3 OPKO Health Inc. Lung Cancer Genomic Testing Product and Solutions
2.14.4 OPKO Health Inc. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 OPKO Health Inc. Recent Developments and Future Plans
2.15 F. Hoffmann-La Roche AG.
2.15.1 F. Hoffmann-La Roche AG. Details
2.15.2 F. Hoffmann-La Roche AG. Major Business
2.15.3 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product and Solutions
2.15.4 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 F. Hoffmann-La Roche AG. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Lung Cancer Genomic Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Lung Cancer Genomic Testing by Company Revenue
3.2.2 Top 3 Lung Cancer Genomic Testing Players Market Share in 2022
3.2.3 Top 6 Lung Cancer Genomic Testing Players Market Share in 2022
3.3 Lung Cancer Genomic Testing Market: Overall Company Footprint Analysis
3.3.1 Lung Cancer Genomic Testing Market: Region Footprint
3.3.2 Lung Cancer Genomic Testing Market: Company Product Type Footprint
3.3.3 Lung Cancer Genomic Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Lung Cancer Genomic Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Lung Cancer Genomic Testing Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Lung Cancer Genomic Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Lung Cancer Genomic Testing Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Lung Cancer Genomic Testing Consumption Value by Type (2018-2029)
6.2 North America Lung Cancer Genomic Testing Consumption Value by Application (2018-2029)
6.3 North America Lung Cancer Genomic Testing Market Size by Country
6.3.1 North America Lung Cancer Genomic Testing Consumption Value by Country (2018-2029)
6.3.2 United States Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Lung Cancer Genomic Testing Consumption Value by Type (2018-2029)
7.2 Europe Lung Cancer Genomic Testing Consumption Value by Application (2018-2029)
7.3 Europe Lung Cancer Genomic Testing Market Size by Country
7.3.1 Europe Lung Cancer Genomic Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
7.3.3 France Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Lung Cancer Genomic Testing Market Size by Region
8.3.1 Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Region (2018-2029)
8.3.2 China Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
8.3.5 India Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Lung Cancer Genomic Testing Consumption Value by Type (2018-2029)
9.2 South America Lung Cancer Genomic Testing Consumption Value by Application (2018-2029)
9.3 South America Lung Cancer Genomic Testing Market Size by Country
9.3.1 South America Lung Cancer Genomic Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Lung Cancer Genomic Testing Market Size by Country
10.3.1 Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Lung Cancer Genomic Testing Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Lung Cancer Genomic Testing Market Drivers
11.2 Lung Cancer Genomic Testing Market Restraints
11.3 Lung Cancer Genomic Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Lung Cancer Genomic Testing Industry Chain
12.2 Lung Cancer Genomic Testing Upstream Analysis
12.3 Lung Cancer Genomic Testing Midstream Analysis
12.4 Lung Cancer Genomic Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Lung Cancer Genomic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Lung Cancer Genomic Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Lung Cancer Genomic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Lung Cancer Genomic Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. CD Genomics Company Information, Head Office, and Major Competitors
Table 6. CD Genomics Major Business
Table 7. CD Genomics Lung Cancer Genomic Testing Product and Solutions
Table 8. CD Genomics Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. CD Genomics Recent Developments and Future Plans
Table 10. Qiagen NV Company Information, Head Office, and Major Competitors
Table 11. Qiagen NV Major Business
Table 12. Qiagen NV Lung Cancer Genomic Testing Product and Solutions
Table 13. Qiagen NV Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Qiagen NV Recent Developments and Future Plans
Table 15. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
Table 16. Laboratory Corporation of America Holdings Major Business
Table 17. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product and Solutions
Table 18. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Table 20. NeoGenomics Laboratories Company Information, Head Office, and Major Competitors
Table 21. NeoGenomics Laboratories Major Business
Table 22. NeoGenomics Laboratories Lung Cancer Genomic Testing Product and Solutions
Table 23. NeoGenomics Laboratories Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. NeoGenomics Laboratories Recent Developments and Future Plans
Table 25. Agilent Technologies Inc. Company Information, Head Office, and Major Competitors
Table 26. Agilent Technologies Inc. Major Business
Table 27. Agilent Technologies Inc. Lung Cancer Genomic Testing Product and Solutions
Table 28. Agilent Technologies Inc. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Agilent Technologies Inc. Recent Developments and Future Plans
Table 30. Illumina Inc. Company Information, Head Office, and Major Competitors
Table 31. Illumina Inc. Major Business
Table 32. Illumina Inc. Lung Cancer Genomic Testing Product and Solutions
Table 33. Illumina Inc. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Illumina Inc. Recent Developments and Future Plans
Table 35. Thermo Fischer Scientific Inc. Company Information, Head Office, and Major Competitors
Table 36. Thermo Fischer Scientific Inc. Major Business
Table 37. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product and Solutions
Table 38. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Thermo Fischer Scientific Inc. Recent Developments and Future Plans
Table 40. Abbott Laboratories Inc. Company Information, Head Office, and Major Competitors
Table 41. Abbott Laboratories Inc. Major Business
Table 42. Abbott Laboratories Inc. Lung Cancer Genomic Testing Product and Solutions
Table 43. Abbott Laboratories Inc. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Abbott Laboratories Inc. Recent Developments and Future Plans
Table 45. Quest Diagnostics Inc. Company Information, Head Office, and Major Competitors
Table 46. Quest Diagnostics Inc. Major Business
Table 47. Quest Diagnostics Inc. Lung Cancer Genomic Testing Product and Solutions
Table 48. Quest Diagnostics Inc. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Quest Diagnostics Inc. Recent Developments and Future Plans
Table 50. OncoDNA Company Information, Head Office, and Major Competitors
Table 51. OncoDNA Major Business
Table 52. OncoDNA Lung Cancer Genomic Testing Product and Solutions
Table 53. OncoDNA Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. OncoDNA Recent Developments and Future Plans
Table 55. Centogene N.V. Company Information, Head Office, and Major Competitors
Table 56. Centogene N.V. Major Business
Table 57. Centogene N.V. Lung Cancer Genomic Testing Product and Solutions
Table 58. Centogene N.V. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Centogene N.V. Recent Developments and Future Plans
Table 60. Admera Health Company Information, Head Office, and Major Competitors
Table 61. Admera Health Major Business
Table 62. Admera Health Lung Cancer Genomic Testing Product and Solutions
Table 63. Admera Health Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Admera Health Recent Developments and Future Plans
Table 65. CeGaT GmbH Company Information, Head Office, and Major Competitors
Table 66. CeGaT GmbH Major Business
Table 67. CeGaT GmbH Lung Cancer Genomic Testing Product and Solutions
Table 68. CeGaT GmbH Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. CeGaT GmbH Recent Developments and Future Plans
Table 70. OPKO Health Inc. Company Information, Head Office, and Major Competitors
Table 71. OPKO Health Inc. Major Business
Table 72. OPKO Health Inc. Lung Cancer Genomic Testing Product and Solutions
Table 73. OPKO Health Inc. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. OPKO Health Inc. Recent Developments and Future Plans
Table 75. F. Hoffmann-La Roche AG. Company Information, Head Office, and Major Competitors
Table 76. F. Hoffmann-La Roche AG. Major Business
Table 77. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product and Solutions
Table 78. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. F. Hoffmann-La Roche AG. Recent Developments and Future Plans
Table 80. Global Lung Cancer Genomic Testing Revenue (USD Million) by Players (2018-2023)
Table 81. Global Lung Cancer Genomic Testing Revenue Share by Players (2018-2023)
Table 82. Breakdown of Lung Cancer Genomic Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Lung Cancer Genomic Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Lung Cancer Genomic Testing Players
Table 85. Lung Cancer Genomic Testing Market: Company Product Type Footprint
Table 86. Lung Cancer Genomic Testing Market: Company Product Application Footprint
Table 87. Lung Cancer Genomic Testing New Market Entrants and Barriers to Market Entry
Table 88. Lung Cancer Genomic Testing Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Lung Cancer Genomic Testing Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Lung Cancer Genomic Testing Consumption Value Share by Type (2018-2023)
Table 91. Global Lung Cancer Genomic Testing Consumption Value Forecast by Type (2024-2029)
Table 92. Global Lung Cancer Genomic Testing Consumption Value by Application (2018-2023)
Table 93. Global Lung Cancer Genomic Testing Consumption Value Forecast by Application (2024-2029)
Table 94. North America Lung Cancer Genomic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Lung Cancer Genomic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Lung Cancer Genomic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Lung Cancer Genomic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Lung Cancer Genomic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Lung Cancer Genomic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Lung Cancer Genomic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Lung Cancer Genomic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Lung Cancer Genomic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Lung Cancer Genomic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Lung Cancer Genomic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Lung Cancer Genomic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Lung Cancer Genomic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Lung Cancer Genomic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Lung Cancer Genomic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Lung Cancer Genomic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Lung Cancer Genomic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Lung Cancer Genomic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Lung Cancer Genomic Testing Raw Material
Table 125. Key Suppliers of Lung Cancer Genomic Testing Raw Materials
Table 1. Global Lung Cancer Genomic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Lung Cancer Genomic Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Lung Cancer Genomic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Lung Cancer Genomic Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. CD Genomics Company Information, Head Office, and Major Competitors
Table 6. CD Genomics Major Business
Table 7. CD Genomics Lung Cancer Genomic Testing Product and Solutions
Table 8. CD Genomics Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. CD Genomics Recent Developments and Future Plans
Table 10. Qiagen NV Company Information, Head Office, and Major Competitors
Table 11. Qiagen NV Major Business
Table 12. Qiagen NV Lung Cancer Genomic Testing Product and Solutions
Table 13. Qiagen NV Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Qiagen NV Recent Developments and Future Plans
Table 15. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
Table 16. Laboratory Corporation of America Holdings Major Business
Table 17. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product and Solutions
Table 18. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Table 20. NeoGenomics Laboratories Company Information, Head Office, and Major Competitors
Table 21. NeoGenomics Laboratories Major Business
Table 22. NeoGenomics Laboratories Lung Cancer Genomic Testing Product and Solutions
Table 23. NeoGenomics Laboratories Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. NeoGenomics Laboratories Recent Developments and Future Plans
Table 25. Agilent Technologies Inc. Company Information, Head Office, and Major Competitors
Table 26. Agilent Technologies Inc. Major Business
Table 27. Agilent Technologies Inc. Lung Cancer Genomic Testing Product and Solutions
Table 28. Agilent Technologies Inc. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Agilent Technologies Inc. Recent Developments and Future Plans
Table 30. Illumina Inc. Company Information, Head Office, and Major Competitors
Table 31. Illumina Inc. Major Business
Table 32. Illumina Inc. Lung Cancer Genomic Testing Product and Solutions
Table 33. Illumina Inc. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Illumina Inc. Recent Developments and Future Plans
Table 35. Thermo Fischer Scientific Inc. Company Information, Head Office, and Major Competitors
Table 36. Thermo Fischer Scientific Inc. Major Business
Table 37. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product and Solutions
Table 38. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Thermo Fischer Scientific Inc. Recent Developments and Future Plans
Table 40. Abbott Laboratories Inc. Company Information, Head Office, and Major Competitors
Table 41. Abbott Laboratories Inc. Major Business
Table 42. Abbott Laboratories Inc. Lung Cancer Genomic Testing Product and Solutions
Table 43. Abbott Laboratories Inc. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Abbott Laboratories Inc. Recent Developments and Future Plans
Table 45. Quest Diagnostics Inc. Company Information, Head Office, and Major Competitors
Table 46. Quest Diagnostics Inc. Major Business
Table 47. Quest Diagnostics Inc. Lung Cancer Genomic Testing Product and Solutions
Table 48. Quest Diagnostics Inc. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Quest Diagnostics Inc. Recent Developments and Future Plans
Table 50. OncoDNA Company Information, Head Office, and Major Competitors
Table 51. OncoDNA Major Business
Table 52. OncoDNA Lung Cancer Genomic Testing Product and Solutions
Table 53. OncoDNA Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. OncoDNA Recent Developments and Future Plans
Table 55. Centogene N.V. Company Information, Head Office, and Major Competitors
Table 56. Centogene N.V. Major Business
Table 57. Centogene N.V. Lung Cancer Genomic Testing Product and Solutions
Table 58. Centogene N.V. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Centogene N.V. Recent Developments and Future Plans
Table 60. Admera Health Company Information, Head Office, and Major Competitors
Table 61. Admera Health Major Business
Table 62. Admera Health Lung Cancer Genomic Testing Product and Solutions
Table 63. Admera Health Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Admera Health Recent Developments and Future Plans
Table 65. CeGaT GmbH Company Information, Head Office, and Major Competitors
Table 66. CeGaT GmbH Major Business
Table 67. CeGaT GmbH Lung Cancer Genomic Testing Product and Solutions
Table 68. CeGaT GmbH Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. CeGaT GmbH Recent Developments and Future Plans
Table 70. OPKO Health Inc. Company Information, Head Office, and Major Competitors
Table 71. OPKO Health Inc. Major Business
Table 72. OPKO Health Inc. Lung Cancer Genomic Testing Product and Solutions
Table 73. OPKO Health Inc. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. OPKO Health Inc. Recent Developments and Future Plans
Table 75. F. Hoffmann-La Roche AG. Company Information, Head Office, and Major Competitors
Table 76. F. Hoffmann-La Roche AG. Major Business
Table 77. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product and Solutions
Table 78. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. F. Hoffmann-La Roche AG. Recent Developments and Future Plans
Table 80. Global Lung Cancer Genomic Testing Revenue (USD Million) by Players (2018-2023)
Table 81. Global Lung Cancer Genomic Testing Revenue Share by Players (2018-2023)
Table 82. Breakdown of Lung Cancer Genomic Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Lung Cancer Genomic Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Lung Cancer Genomic Testing Players
Table 85. Lung Cancer Genomic Testing Market: Company Product Type Footprint
Table 86. Lung Cancer Genomic Testing Market: Company Product Application Footprint
Table 87. Lung Cancer Genomic Testing New Market Entrants and Barriers to Market Entry
Table 88. Lung Cancer Genomic Testing Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Lung Cancer Genomic Testing Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Lung Cancer Genomic Testing Consumption Value Share by Type (2018-2023)
Table 91. Global Lung Cancer Genomic Testing Consumption Value Forecast by Type (2024-2029)
Table 92. Global Lung Cancer Genomic Testing Consumption Value by Application (2018-2023)
Table 93. Global Lung Cancer Genomic Testing Consumption Value Forecast by Application (2024-2029)
Table 94. North America Lung Cancer Genomic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Lung Cancer Genomic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Lung Cancer Genomic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Lung Cancer Genomic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Lung Cancer Genomic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Lung Cancer Genomic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Lung Cancer Genomic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Lung Cancer Genomic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Lung Cancer Genomic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Lung Cancer Genomic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Lung Cancer Genomic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Lung Cancer Genomic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Lung Cancer Genomic Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Lung Cancer Genomic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Lung Cancer Genomic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Lung Cancer Genomic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Lung Cancer Genomic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Lung Cancer Genomic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Lung Cancer Genomic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Lung Cancer Genomic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Lung Cancer Genomic Testing Raw Material
Table 125. Key Suppliers of Lung Cancer Genomic Testing Raw Materials
LIST OF FIGURES
Figure 1. Lung Cancer Genomic Testing Picture
Figure 2. Global Lung Cancer Genomic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Lung Cancer Genomic Testing Consumption Value Market Share by Type in 2022
Figure 4. Liquid Biopsy
Figure 5. Tissue Biopsy
Figure 6. Global Lung Cancer Genomic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Lung Cancer Genomic Testing Consumption Value Market Share by Application in 2022
Figure 8. Hospitals/Clinics Picture
Figure 9. Research Organization Picture
Figure 10. Diagnostic Laboratories Picture
Figure 11. Global Lung Cancer Genomic Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Lung Cancer Genomic Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Lung Cancer Genomic Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Lung Cancer Genomic Testing Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Lung Cancer Genomic Testing Consumption Value Market Share by Region in 2022
Figure 16. North America Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Lung Cancer Genomic Testing Revenue Share by Players in 2022
Figure 22. Lung Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Lung Cancer Genomic Testing Market Share in 2022
Figure 24. Global Top 6 Players Lung Cancer Genomic Testing Market Share in 2022
Figure 25. Global Lung Cancer Genomic Testing Consumption Value Share by Type (2018-2023)
Figure 26. Global Lung Cancer Genomic Testing Market Share Forecast by Type (2024-2029)
Figure 27. Global Lung Cancer Genomic Testing Consumption Value Share by Application (2018-2023)
Figure 28. Global Lung Cancer Genomic Testing Market Share Forecast by Application (2024-2029)
Figure 29. North America Lung Cancer Genomic Testing Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Lung Cancer Genomic Testing Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Lung Cancer Genomic Testing Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Lung Cancer Genomic Testing Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Lung Cancer Genomic Testing Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Lung Cancer Genomic Testing Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 39. France Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Lung Cancer Genomic Testing Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Lung Cancer Genomic Testing Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Lung Cancer Genomic Testing Consumption Value Market Share by Region (2018-2029)
Figure 46. China Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 49. India Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Lung Cancer Genomic Testing Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Lung Cancer Genomic Testing Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Lung Cancer Genomic Testing Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Lung Cancer Genomic Testing Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Lung Cancer Genomic Testing Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Lung Cancer Genomic Testing Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 63. Lung Cancer Genomic Testing Market Drivers
Figure 64. Lung Cancer Genomic Testing Market Restraints
Figure 65. Lung Cancer Genomic Testing Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Lung Cancer Genomic Testing in 2022
Figure 68. Manufacturing Process Analysis of Lung Cancer Genomic Testing
Figure 69. Lung Cancer Genomic Testing Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Lung Cancer Genomic Testing Picture
Figure 2. Global Lung Cancer Genomic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Lung Cancer Genomic Testing Consumption Value Market Share by Type in 2022
Figure 4. Liquid Biopsy
Figure 5. Tissue Biopsy
Figure 6. Global Lung Cancer Genomic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Lung Cancer Genomic Testing Consumption Value Market Share by Application in 2022
Figure 8. Hospitals/Clinics Picture
Figure 9. Research Organization Picture
Figure 10. Diagnostic Laboratories Picture
Figure 11. Global Lung Cancer Genomic Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Lung Cancer Genomic Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Lung Cancer Genomic Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Lung Cancer Genomic Testing Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Lung Cancer Genomic Testing Consumption Value Market Share by Region in 2022
Figure 16. North America Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Lung Cancer Genomic Testing Revenue Share by Players in 2022
Figure 22. Lung Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Lung Cancer Genomic Testing Market Share in 2022
Figure 24. Global Top 6 Players Lung Cancer Genomic Testing Market Share in 2022
Figure 25. Global Lung Cancer Genomic Testing Consumption Value Share by Type (2018-2023)
Figure 26. Global Lung Cancer Genomic Testing Market Share Forecast by Type (2024-2029)
Figure 27. Global Lung Cancer Genomic Testing Consumption Value Share by Application (2018-2023)
Figure 28. Global Lung Cancer Genomic Testing Market Share Forecast by Application (2024-2029)
Figure 29. North America Lung Cancer Genomic Testing Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Lung Cancer Genomic Testing Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Lung Cancer Genomic Testing Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Lung Cancer Genomic Testing Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Lung Cancer Genomic Testing Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Lung Cancer Genomic Testing Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 39. France Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Lung Cancer Genomic Testing Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Lung Cancer Genomic Testing Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Lung Cancer Genomic Testing Consumption Value Market Share by Region (2018-2029)
Figure 46. China Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 49. India Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Lung Cancer Genomic Testing Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Lung Cancer Genomic Testing Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Lung Cancer Genomic Testing Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Lung Cancer Genomic Testing Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Lung Cancer Genomic Testing Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Lung Cancer Genomic Testing Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Lung Cancer Genomic Testing Consumption Value (2018-2029) & (USD Million)
Figure 63. Lung Cancer Genomic Testing Market Drivers
Figure 64. Lung Cancer Genomic Testing Market Restraints
Figure 65. Lung Cancer Genomic Testing Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Lung Cancer Genomic Testing in 2022
Figure 68. Manufacturing Process Analysis of Lung Cancer Genomic Testing
Figure 69. Lung Cancer Genomic Testing Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
